CN1611606A - 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 - Google Patents
单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 Download PDFInfo
- Publication number
- CN1611606A CN1611606A CN 200310111299 CN200310111299A CN1611606A CN 1611606 A CN1611606 A CN 1611606A CN 200310111299 CN200310111299 CN 200310111299 CN 200310111299 A CN200310111299 A CN 200310111299A CN 1611606 A CN1611606 A CN 1611606A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- plasmid
- puc18
- vector
- shrna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title claims abstract description 42
- 239000013598 vector Substances 0.000 title claims description 95
- 238000000034 method Methods 0.000 title claims description 42
- 239000004055 small Interfering RNA Substances 0.000 claims abstract description 97
- 108091027967 Small hairpin RNA Proteins 0.000 claims abstract description 84
- 239000013604 expression vector Substances 0.000 claims abstract description 31
- 210000004962 mammalian cell Anatomy 0.000 claims abstract description 28
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- 102000004190 Enzymes Human genes 0.000 claims description 149
- 108090000790 Enzymes Proteins 0.000 claims description 149
- 239000013612 plasmid Substances 0.000 claims description 131
- 108020004414 DNA Proteins 0.000 claims description 58
- 239000012634 fragment Substances 0.000 claims description 46
- 240000004922 Vigna radiata Species 0.000 claims description 26
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 26
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 26
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 26
- 108091008146 restriction endonucleases Proteins 0.000 claims description 19
- 108091081021 Sense strand Proteins 0.000 claims description 18
- 108020004459 Small interfering RNA Proteins 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 238000000137 annealing Methods 0.000 claims description 12
- 238000001976 enzyme digestion Methods 0.000 claims description 12
- 238000010276 construction Methods 0.000 claims description 10
- 102000053602 DNA Human genes 0.000 claims description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 6
- 230000000692 anti-sense effect Effects 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 49
- 230000000694 effects Effects 0.000 abstract description 13
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 abstract description 5
- 230000009368 gene silencing by RNA Effects 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 description 54
- 210000004027 cell Anatomy 0.000 description 31
- 241000725303 Human immunodeficiency virus Species 0.000 description 27
- 239000000370 acceptor Substances 0.000 description 22
- 230000008521 reorganization Effects 0.000 description 15
- 108091032955 Bacterial small RNA Proteins 0.000 description 14
- 230000002452 interceptive effect Effects 0.000 description 14
- 239000013600 plasmid vector Substances 0.000 description 14
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 13
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 12
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 8
- 210000000265 leukocyte Anatomy 0.000 description 8
- 230000008676 import Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000003321 amplification Effects 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101710091045 Envelope protein Proteins 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 101710188315 Protein X Proteins 0.000 description 2
- 108091008874 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- 241000218636 Thuja Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 1
- 108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 1
- 101710121417 Envelope glycoprotein Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000009668 clonal growth Effects 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310111299 CN1276976C (zh) | 2003-10-30 | 2003-10-30 | 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310111299 CN1276976C (zh) | 2003-10-30 | 2003-10-30 | 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1611606A true CN1611606A (zh) | 2005-05-04 |
CN1276976C CN1276976C (zh) | 2006-09-27 |
Family
ID=34759374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310111299 Expired - Fee Related CN1276976C (zh) | 2003-10-30 | 2003-10-30 | 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1276976C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1734811A2 (en) * | 2003-11-21 | 2006-12-27 | Revivicor, Inc. | Use of interfering rna in the production of transgenic animals |
CN1307311C (zh) * | 2005-04-27 | 2007-03-28 | 中国医学科学院医药生物技术研究所 | 一种可同时表达多种shRNA的载体pCSH1-n及其构建方法 |
US7727970B2 (en) | 2004-03-05 | 2010-06-01 | Benitec, Inc. | Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus |
CN101139615B (zh) * | 2007-08-06 | 2011-10-19 | 湖北大学 | 一种快速高效构建哺乳动物细胞rna干扰载体及其验证载体的方法 |
CN101068926B (zh) * | 2004-03-05 | 2013-01-02 | 贝尼泰克生物制药有限公司 | 用于RNAi试剂同时递送的多启动子表达盒及用途 |
CN104250645A (zh) * | 2013-06-27 | 2014-12-31 | 彭长庚 | 一种rna片段及其制备方法和用途 |
-
2003
- 2003-10-30 CN CN 200310111299 patent/CN1276976C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1734811A2 (en) * | 2003-11-21 | 2006-12-27 | Revivicor, Inc. | Use of interfering rna in the production of transgenic animals |
EP1734811A4 (en) * | 2003-11-21 | 2009-03-25 | Revivicor Inc | USE OF INTERFERENCE RNA IN TRANSGENIC ANIMAL PRODUCTION |
US7727970B2 (en) | 2004-03-05 | 2010-06-01 | Benitec, Inc. | Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus |
US8283461B2 (en) | 2004-03-05 | 2012-10-09 | Benitec, Inc. | Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
CN101068926B (zh) * | 2004-03-05 | 2013-01-02 | 贝尼泰克生物制药有限公司 | 用于RNAi试剂同时递送的多启动子表达盒及用途 |
US8691967B2 (en) | 2004-03-05 | 2014-04-08 | Benitec, Inc. | Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
CN1307311C (zh) * | 2005-04-27 | 2007-03-28 | 中国医学科学院医药生物技术研究所 | 一种可同时表达多种shRNA的载体pCSH1-n及其构建方法 |
CN101139615B (zh) * | 2007-08-06 | 2011-10-19 | 湖北大学 | 一种快速高效构建哺乳动物细胞rna干扰载体及其验证载体的方法 |
CN104250645A (zh) * | 2013-06-27 | 2014-12-31 | 彭长庚 | 一种rna片段及其制备方法和用途 |
WO2014206219A1 (zh) * | 2013-06-27 | 2014-12-31 | 昆山彭济凯丰生物科技有限公司 | 一种rna片段及其制备方法和用途 |
CN104250645B (zh) * | 2013-06-27 | 2017-05-03 | 昆山彭济凯丰生物科技有限公司 | 一种rna片段及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1276976C (zh) | 2006-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1254543C (zh) | 方法 | |
CN1257284C (zh) | 一种体外阻断乙肝病毒表达的方法 | |
CN1039616A (zh) | 巴斯德毕赤酵母醇氧化酶ii调节区 | |
CN1154744C (zh) | 不含有病毒编码序列的逆病毒载体 | |
CN1468304A (zh) | 蛋白质功能域的制备方法 | |
CN1209875A (zh) | 根据人类hiv病毒株的表型药物敏感性控制hiv阳性病人化疗的方法 | |
CN1208469C (zh) | 用于检测人免疫缺陷病毒-1型的引物、试剂盒和方法 | |
CN1191574A (zh) | 合成的哺乳动物染色体和其构建方法 | |
CN1252261C (zh) | 无细胞蛋白质合成用转录模板的设计、构建及使用其的稀释分批式麦胚芽无细胞蛋白质的合成法 | |
CN1276976C (zh) | 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法 | |
CN111484994B (zh) | CRISPR-Cas9特异性敲除猪Fah、Rag2双基因的方法 | |
CN1206359C (zh) | 含有携带剪接受体的基因工程细胞非编码序列的高效逆转录病毒载体 | |
CN103923942B (zh) | 一种表达猪端粒酶反转酶转座子载体及其构建方法与在建立猪永生化细胞系中的应用 | |
CN1249244C (zh) | 去除抗生素耐药性和/或使质粒稳定的方法,该方法构建的载体和转化的宿主细胞及其应用 | |
CN101045933A (zh) | 一种适冷蛋白酶的基因mcp01及其制备方法 | |
CN1800388A (zh) | 八种人源miRNA | |
CN101054577A (zh) | 抑制Bax基因表达的siRNA和表达载体及其作为乙型病毒性肝炎治疗药物的应用 | |
CN101068928A (zh) | RNAi转染子的改良选择方法 | |
CN1570115A (zh) | 优化的sars冠状病毒刺突蛋白基因 | |
CN1820081A (zh) | 分析基因导入位点的方法 | |
CN1746304A (zh) | 固氮负调节基因突变的泌铵工程菌的构建及应用 | |
CN1545550A (zh) | 含泡沫逆转录病毒包膜蛋白的感染性嗜肝dna病毒颗粒的制备及其使用方法 | |
CN1884496A (zh) | 逆转录病毒包装细胞系和肝细胞靶向性导入方法 | |
CN1252262C (zh) | 双启动子DNA疫苗表达载体pCMVnir及其制备方法 | |
CN1291020C (zh) | 小麦TaGI1基因及其克隆与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: STATE WUCHANG SHIPBUILDING PLANT Free format text: FORMER NAME OR ADDRESS: FENG JIANGNAN |
|
CP03 | Change of name, title or address |
Address after: 430060 Hubei Province, Wuhan city Wuchang District Ziyang Road No. 2 Patentee after: Wuchang Shipyard Address before: 430074 room 7-3, building 309, East Lake New Technology Development Zone, Wuchang, Hubei, Wuhan Patentee before: Feng Jiangnan |
|
C56 | Change in the name or address of the patentee |
Owner name: WUCHANG SHIP HEAVY INDUSTRY CO., LTD. Free format text: FORMER NAME: STATE-OWNED WUCHANG SHIPBUILDING PLANT |
|
CP01 | Change in the name or title of a patent holder |
Address after: Ziyang road in Hubei province Wuhan city Wuchang District No. 2 Patentee after: Wuchang Shipbuilding Industry Co., Ltd. Address before: Ziyang road in Hubei province Wuhan city Wuchang District No. 2 Patentee before: Wuchang Shipyard |
|
ASS | Succession or assignment of patent right |
Owner name: FENG JIANGNAN Free format text: FORMER OWNER: WUCHANG SHIPBUILDING INDUSTRY CO., LTD. Effective date: 20120706 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430060 WUHAN, HUBEI PROVINCE TO: 430074 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120706 Address after: 430074 Wuchang East Lake New Technology Development Zone Venture Center, Wuhan, Hubei, 7-3-510 Patentee after: Feng Jiangnan Address before: 430060 Hubei Province, Wuhan city Wuchang District Ziyang Road No. 2 Patentee before: Wuchang Shipbuilding Industry Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160826 Address after: 430071, Hubei, Wuhan province East Lake New Technology Development Zone, 666 hi tech Avenue, Wuhan national biological industry (nine peaks innovation) base, B6 building, 2 floor Patentee after: WUHAN ANDIJINGSAI BIOTECHNOLOGY CO., LTD. Address before: 430074 Wuchang East Lake New Technology Development Zone Venture Center, Wuhan, Hubei, 7-3-510 Patentee before: Feng Jiangnan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190514 Address after: 430000 Block 7-3-510, Guandong Science and Technology Industrial Park, Donghu Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan Xi Ma Biological Technology Co. Ltd. Address before: 430071, 2nd Floor, B6 Building, Wuhan National Biological Industry (Jiufeng Innovation) Base, 666 High-tech Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: WUHAN ANDIJINGSAI BIOTECHNOLOGY CO., LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060927 Termination date: 20191030 |